Similarly, anti-IL-17 treatment had little impact on the T cell-mediated colitis that develops in IL-10-deficient mice or in RAG-deficient recipients of IL-10-deficient CD4+ T cells, although the colitis was dependant on IL-23 (Yen et al., 2006). Here, IL10 is linked to colitis.